Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia - First Episode Study
Brain Imaging Study and Brief Treatment - People with Hallucinations and Delusions
Sponsor: NIMH
Enrolling: Male and Female Patients
Study Length: 1 Months
Clinic Visits: 6
IRB Number: 7474
Contact: Hannah Hesson: 646-774-5209 / hannah.hesson@nyspi.columbia.edu
Additional Study Information: Are you between the ages of 18-35? Do you have schizophrenia or schizoaffective disorder? Researchers at the New York State Psychiatric Institute are currently seeking participants who are interested in a brief trial of anti-psychotic medication. This study will include: - magnetic resonance imaging (MRI) - a physical exam - clinical and neurocognitive assessments over a four-week period. If all elements of the study are completed, participants can make up to $550.00. For further information about the study and your eligibility, please contact Hannah at the New York State Psychiatric Institute at 646-774-5209.
This study is closed
Investigator
Lawrence Kegeles, MD
Do You Qualify?
Are you between the ages of 18-35? Yes No
Have you ever had unusual thoughts, experiences or feelings? Yes No
Do you live in the New York Metropolitan Area? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Hannah Hesson
hannah.hesson@nyspi.columbia.edu
646-774-5209
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE